Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-02

Clinical Trial Update: WelTelOAKTREE: Text Messaging to Support Patients With HIV/AIDS in British Columbia [NA]

View source ↗

Summary

Clinical trial update indicating the WelTelOAKTREE study assessing text messaging to support HIV treatment adherence has completed in British Columbia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: BC Women's Hospital & Health Centre | Conditions: HIV, Medication Adherence | NA | Status: COMPLETED